Drug Patents owned by Adhera
1. List of Prestalia drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6696481 | ADHERA | Salt of perindopril and pharmaceutical compositions containing it |
Apr, 2023
(2 months from now) | |
| US7846961 | ADHERA | α crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it |
Oct, 2029
(6 years from now) | |
Drugs and Companies using AMLODIPINE BESYLATE; PERINDOPRIL ARGININE ingredient
Market Authorisation Date: 21 January, 2015
Treatment: Treatment of hypertension
Dosage: TABLET;ORAL
How can I launch a generic of PRESTALIA before it's patent expiration?
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic